Skip to main content

Want a detailed portfolio tracker?

Neuphoria Therapeutics (NEUP) P/E (2024 - 2026)

Neuphoria Therapeutics (NEUP) P/E from Dec 23, 2024 to Jul 21, 2026. The TTM Neuphoria Therapeutics (NEUP) P/E is -0.80. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Neuphoria Therapeutics (NEUP)

YearP/EChange
2026-0.80-141.73%
20251.93-656.82%
2024-0.35N/A

Comparison Neuphoria Therapeutics (NEUP) P/E with competitors

Neuphoria Therapeutics (NEUP) P/E is -0.80.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.21%
NBYStablecoin Development Corp0.00-100.53%
ENLVEnlivex Ltd0.07-109.30%
FGENFibroGen Inc0.24-129.86%
CHRSCoherus Biosciences Inc0.85-205.54%
FBIOFortress Biotech Inc0.95-218.04%
ORMPOramed Pharmaceuticals Inc1.50-286.95%
AGENAgenus Inc3.01-474.34%
INVAInnoviva Inc3.15-492.30%
VXRTVaxart Inc3.55-541.52%
CRMDCorMedix Inc3.63-551.31%
CVACCureVac N.V.4.45-652.96%
GLPGGalapagos NV4.86-704.36%
SRPTSarepta Therapeutics Inc4.88-707.25%
ABEOAbeona Therapeutics Inc5.39-770.11%
ABUSArbutus Biopharma Corp5.60-796.00%
ZVRAZevra Therapeutics Inc5.89-832.27%
SPROSpero Therapeutics Inc6.23-874.71%
CGENCompugen Ltd6.31-885.34%
RIGLRigel Pharmaceuticals6.87-954.76%
SLXNSilexion Therapeutics Corp7.30-1007.50%
OMEROmeros Corporation9.26-1251.63%
AUPHAurinia Pharmaceuticals Inc9.58-1292.20%
PLXProtalix BioTherapeutics Inc10.89-1454.65%
ACADAcadia Pharmaceuticals Inc11.73-1558.82%
TBPHTheravance Biopharma Inc12.26-1625.20%
ADMAAdma Biologics Inc12.42-1644.60%
HRMYHarmony Biosciences Holdings Inc13.82-1818.99%
SABSSAB Biotherapeutics Inc14.14-1858.30%
NAGENiagen Bioscience Inc14.82-1943.12%
INCYIncyte Corp15.82-2068.05%
REGNRegeneron Pharmaceuticals Inc15.86-2072.29%
PBYIPuma Biotechnology Inc17.32-2253.77%
CPRXCatalyst Pharmaceuticals Inc17.44-2269.15%
EXELExelixis Inc17.54-2281.43%
TGTXTG Therapeutics Inc18.97-2459.05%
MDXGMimedx Group Inc20.55-2656.38%
XOMAXOMA Royalty Corp22.87-2945.29%
ARGXArgen X SE24.30-3122.33%
CTMXCytomX Therapeutics Inc24.82-3187.40%
XOMAOXOMA Royalty Corp25.34-3252.54%
HALOHalozyme Therapeutics Inc25.62-3287.23%
XOMAPXOMA Royalty Corp25.67-3293.00%
VRTXVertex Pharmaceuticals Inc27.99-3582.15%
RPRXRoyalty Pharma plc - Class A28.69-3668.33%
SLNOSoleno Therapeutics Inc29.02-3709.10%
ASNDAscendis Pharma A/S30.09-3842.22%
LGNDLigand Pharmaceuticals Inc - Class B37.91-4815.72%
APLSApellis Pharmaceuticals Inc39.02-4953.69%
BMRNBiomarin Pharmaceutical Inc42.21-5350.56%
KRYSKrystal Biotech Inc45.34-5740.09%
ONCBeiGene Ltd69.54-8749.86%
PHARPharming Group N.V.75.03-9432.14%
TECHBio-Techne Corp101.96-12782.21%
VCELVericel Corp109.92-13772.69%
ALNYAlnylam Pharmaceuticals Inc117.96-14773.22%
GMABGenmab140.29-17550.22%
TLXTelix Pharmaceuticals Ltd162.15-20269.56%
CORTCorcept Therapeutics Inc212.86-26576.52%